{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T04:04:28Z","timestamp":1750565068145,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 76-year-old man with hepatocellular carcinoma was referred for liver radioembolization. Given a prior left hemihepatectomy, it was clinically important to consider potentially irradiated healthy liver at planning. Thus, at the SPECT\/CT imaging of the scout dose <jats:sup>166<\/jats:sup>Ho-microparticles before injected superselectively in the right hepatic artery, <jats:sup>99m<\/jats:sup>Tc-mebrofenin was injected intravenously, and functional volumetry SPECT was performed simultaneously. Based on the 2 image sets, the nonirradiated healthy liver was calculated as 1589 mL (functional liver reserve of 85.5% on <jats:sup>99m<\/jats:sup>Tc-mebrofenin SPECT). Posttreatment dosimetry calculations showed optimal normal tissue and tumor absorbed doses, and the patient is clinically well after 3 months.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004732","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T23:00:08Z","timestamp":1686265208000},"page":"719-721","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Radioembolization Planning With Dual-Isotope Acquisition of 166Ho-Labeled Microparticles and 99mTc-Mebrofenin"],"prefix":"10.1097","volume":"48","author":[{"given":"S\u00e1ndor","family":"Czibor","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Bibok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9nes","family":"Horv\u00e1thy","sequence":"additional","affiliation":[{"name":"Interventional Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriszti\u00e1n","family":"F\u00e1bi\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Gy\u00f6rke","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-9966-29-70","article-title":"Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial","volume":"29","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00270-022-03187-y","article-title":"Holmium-166 radioembolization: current status and future prospective","volume":"45","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests: a review","volume":"257","year":"2013","journal-title":"Ann Surg"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2967\/jnumed.109.069724","article-title":"(99 m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13304-020-00907-2","article-title":"The role of hepatobiliary scintigraphy combined with SPECT\/CT in predicting severity of liver failure before major hepatectomy: a single-center pilot study","volume":"73","year":"2021","journal-title":"Updates Surg"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/ijnm.IJNM_72_18","article-title":"Liver functional volumetry by Tc-99m mebrofenin hepatobiliary scintigraphy before major liver resection: a game changer","volume":"33","year":"2018","journal-title":"Indian J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.hpb.2016.06.006","article-title":"Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection","volume":"18","year":"2016","journal-title":"HPB (Oxford)"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2967\/jnumed.118.224394","article-title":"A pilot study on hepatobiliary scintigraphy to monitor regional liver function in 90Y radioembolization","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MNM.0000000000001224","article-title":"The utility of 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT\/CT for selective internal radiation therapy in hepatocellular carcinoma","volume":"41","year":"2020","journal-title":"Nucl Med Commun"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40658-020-0280-9","article-title":"Simultaneous 166Ho\/99mTc dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization","volume":"7","year":"2020","journal-title":"EJNMMI Phys"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40658-020-00317-8","article-title":"Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible","volume":"7","year":"2020","journal-title":"EJNMMI Phys"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/85.1.101","article-title":"Technetium-99m as a scanning agent","volume":"85","year":"1965","journal-title":"Radiology"},{"key":"bib13-20250621","first-page":"8","article-title":"Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid","volume":"24","year":"1983","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:25Z","timestamp":1750532725000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004732","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}